Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: Nat Rev Urol. 2010 Feb 9;7(3):127–135. doi: 10.1038/nrurol.2010.4

Table 1.

Current chronic prostatitis/chronic pelvic pain syndrome drug treatment trials*

Drug Class Placebo-controlled Route of administration ClinicalTrials.gov identifier
CC-10004 Anti-inflammatory No Oral NCT00701311
Botulinum toxin A Anticholinergic Yes Intrasphincteric NCT00464373
Botulinum toxin A Lidocaine Anticholinergic Anesthetic No Intraprostatic NCT00529386
Pregabalin Anticonvulsant Yes Oral NCT00371033
Tolterodine Tamsulosin Antimuscarinic Alpha-blocker Yes Oral NCT00913315
Tanezumab Anti-nerve growth factor Yes Intravenous NCT00826514
*

These drugs are registered in clinical trials that are either active, recruiting, or not yet recruiting.